• SplineAI: Specializing in Healthcare AI Products & Services

  • Cover Story

    SplineAI: Specializing in Healthcare AI Products & Services

    We are in the middle of the fourth Industrial revolution driven by Artificial Intelligence and High-Performance computer processors. The age-old rampant Healthcare system is seen undergoing a major revamp propelled by AI. Yet, conventional healthcare practices resist major changes. Even today, patients have no choice but to linger for hours to get their checkups done. While the clinics routinely order for unnecessary medical tests to charge lump sum from the patients, the physicians with almost no empathy prescribe medicines without going deep to understand the patient’s concerns. This didn’t go unnoticed by Syed Hussain who to bring AI to provide a holistic solution for enhancing healthcare. A Ph.D. in AI from IIT Kharagpur, Syed understood that AI can make a real difference to...

Content

Startups are Now Offering Personalized Healthcare Services

Nandini Mukherjee, Managing Editor

Healthcare Landscape & Roadmap towards Complete Digitization

Arun Rangamani, SVP-Analytics & Technology, SCIO Health Analytics

How Improper Posture Can Impact Adversely On Your Spine

Dr. Avinash K.M, Senior Consultant, Neurosurgery & Interventional Neurosurgery, Columbia Asia Hospital

Healthcare Analytics - Roadmap for Success

Vijay Venkatesan, Chief Data Officer, Providence Health & Services

Changing Face of Healthcare: Companies for Digital Health & Social Impact

Sachin Malhotra, CEO, Tech Care for All

Creating a Health Workforce for India’s Seniors: Geriatric Caregivers

Priya Anant, Co-Founder, Life Circle Health Services Pvt. Ltd.

Health Care as it could Be in 2030

Alan V. Abramson, SVP - Information Services & Technology and CIO, HealthPartners

Using Technology to Build Transparency & Trusted Healthcare

Pankaj Mittal, Co-founder & Chief Technology Officer, AB Hospitals

The Great Indian Health Insurance Revolution

Vivek Srivastava, CEO, HealthCare at HOME, India

The 'Big Pharma TilT' towards Artifical Intelligence

Jasmine Gorimar, Senior Commercial, Glaxo SmithKline (GSK)